Your request to link to rcsb for Ribosyldihydronicotinamide dehydrogenase [quinone]


  • 1QR2: human quinone reductase type 2 (10.1021/BI990799V )
  • 1SG0: crystal structure analysis of qr2 in complex with resveratrol (10.1021/BI049162O )
  • 1XI2: quinone reductase 2 in complex with cancer prodrug cb1954 (10.1016/J.BBRC.2005.08.081 )
  • 1ZX1: human quinone oxidoreductase 2 (nqo2) in complex with the cytostatic prodrug cb1954
  • 2BZS: binding of anti-cancer prodrug cb1954 to the activating enzyme nqo2 revealed by the crystal structure of their complex. (10.1021/JM050730N )
  • 2QMY: quinone reductase 2 in complex with adrenochrome
  • 2QMZ: quinone reductase 2 in complex with dopamine
  • 2QR2: human quinone reductase type 2, complex with menadione (10.1021/BI990799V )
  • 2QWX: crystal structure of quinone reductase ii (10.1042/BJ20071373 )
  • 2QX4: crystal structure of quinone reductase ii (10.1042/BJ20071373 )
  • 2QX6: crystal structure of quinone reductase ii (10.1042/BJ20071373 )
  • 2QX8: crystal structure of quinone reductase ii (10.1042/BJ20071373 )
  • 2QX9: crystal structure of quinone reductase ii (10.1042/BJ20071373 )
  • 3FW1: quinone reductase 2 (10.1186/1472-6807-9-7 )
  • 3G5M: synthesis of casimiroin and optimization of its quinone reductase 2 and aromatase inhibitory activity (10.1021/JM801335Z )
  • 3GAM: synthesis of casimiroin and optimization of its quinone reductase 2 and aromatase inhibitory activity (10.1021/JM801335Z )
  • 3NFR: casimiroin analog inhibitor of quinone reductase 2
  • 3NHF: x-ray crystallographic structure activity relationship (sar) of casimiroin and its analogs bound to human quinone reductase 2
  • 3NHJ: x-ray crystallographic structure activity relationship (sar) of casimiroin and its analogs bound to human quinone reductase 2
  • 3NHK: x-ray crystallographic structure activity relationship (sar) of casimiroin and its analogs bound to human quinone reductase 2
  • 3NHL: x-ray crystallographic structure activity relationship (sar) of casimiroin and its analogs bound to human quinone reductase 2
  • 3NHP: x-ray crystallographic structure activity relationship (sar) of casimiroin and its analogs bound to human quinone reductase 2
  • 3NHR: x-ray crystallographic structure activity relationship (sar) of casimiroin and its analogs bound to human quinone reductase 2
  • 3NHS: x-ray crystallographic structure activity relationship (sar) of casimiroin and its analogs bound to human quinone reductase 2
  • 3NHU: x-ray crystallographic structure activity relationship (sar) of casimiroin and its analogs bound to human quinone reductase 2
  • 3NHW: x-ray crystallographic structure activity relationship (sar) of casimiroin and its analogs bound to human quinone reductase 2
  • 3NHY: x-ray crystallographic structure activity relationship (sar) of casimiroin and its analogs bound to human quinone reductase 2
  • 3O2N: x-ray crystallographic structure activity relationship (sar) of casimiroin and its analogs bound to human quinone reductase 2
  • 3O73: crystal structure of quinone reductase 2 in complex with the indolequinone mac627 (10.1002/CBIC.201100085 )
  • 3OVM: x-ray structural study of quinone reductase ii inhibition by compounds with micromolar to nanomolar range ic50 values (10.1002/PRO.647 )
  • 3OWH: x-ray structural study of quinone reductase ii inhibition by compounds with micromolar to nanomolar range ic50 values (10.1002/PRO.647 )
  • 3OWX: x-ray structural study of quinone reductase ii inhibition by compounds with micromolar to nanomolar range ic50 values (10.1002/PRO.647 )
  • 3OX1: x-ray structural study of quinone reductase ii inhibition by compounds with micromolar to nanomolar range ic50 values (10.1002/PRO.647 )
  • 3OX2: x-ray structural study of quinone reductase ii inhibition by compounds with micromolar to nanomolar range ic50 values (10.1002/PRO.647 )
  • 3OX3: x-ray structural study of quinone reductase ii inhibition by compounds with micromolar to nanomolar range ic50 values (10.1002/PRO.647 )
  • 3TE7: quinone oxidoreductase (nq02) bound to the imidazoacridin-6-one 5a1 (10.1021/JM200416E )
  • 3TEM: quinone oxidoreductase (nq02) bound to the imidazoacridin-6-one 6a1 (10.1021/JM200416E )
  • 3TZB: quinone oxidoreductase (nq02) bound to nsc13000 (10.1158/1535-7163.MCT-11-0543 )
  • 3UXE: design, synthesis and biological evaluation of potent quinoline and pyrroloquinoline ammosamide analogues as inhibitors for quinone reductase 2 (10.1021/JM201251C )
  • 3UXH: design, synthesis and biological evaluation of potetent quinoline and pyrroloquinoline ammosamide analogues as inhibitors of quinone reductase 2 (10.1021/JM201251C )
  • 4FGJ: oxidized quinone reductase 2 in complex with primaquine
  • 4FGK: oxidized quinone reductase 2 in complex with chloroquine
  • 4FGL: reduced quinone reductase 2 in complex with chloroquine
  • 4GQI: synthesis of novel mt3 receptor ligands via unusual knoevenagel condensation (10.1016/J.BMCL.2012.10.005 )
  • 4GR9: synthesis of novel mt3 receptor ligands via unusual knoevenagel condensation (10.1016/J.BMCL.2012.10.005 )
  • 4QOD: the value crystal structure of apo quinone reductase 2 at 1.35a
  • 4QOE: the value 'crystal structure of fad quinone reductase 2 at 1.45a
  • 4QOF: crystal structure of fmn quinone reductase 2 at 1.55a
  • 4QOG: crystal structure of fad quinone reductase 2 in complex with melatonin at 1.4a
  • 4QOH: crystal structure of fad quinone reductase 2 in complex with resveratrol at 1.6a
  • 4QOI: crystal structure of fmn quinone reductase 2 in complex with melatonin at 1.55a
  • 4QOJ: crystal structure of fmn quinone reductase 2 in complex with resveratrol at 1.85a
  • 4U7F: reduced quinone reductase 2 in complex with ck2 inhibitor dmat (10.1021/BI500959T )
  • 4U7G: oxidized quinone reductase 2 in complex with ck2 inhibitor tbbz (10.1021/BI500959T )
  • 4U7H: oxidized quinone reductase 2 in complex with ck2 inhibitor dmat (10.1021/BI500959T )
  • 4XDG: crystal structure of quinone reductase ii in complex with 2-(4- aminophenyl)-5-methoxy-1-oxy-indol-3-one molecule (10.3390/MOLECULES22020210 )
  • 4XDH: crystal structure of quinone reductase ii in complex with a 2-(4- methoxy-phenyl)-5-methoxy-indol-3-one molecule (10.3390/MOLECULES22020210 )
  • 4ZVK: reduced quinone reductase 2 in complex with ethidium (10.1021/ACS.BIOCHEM.5B00884 )
  • 4ZVL: oxidized quinone reductase 2 in complex with acridine orange (10.1021/ACS.BIOCHEM.5B00884 )
  • 4ZVM: oxidized quinone reductase 2 in complex with doxorubicin (10.1021/ACS.BIOCHEM.5B00884 )
  • 4ZVN: reduced quinone reductase 2 in complex with acridine orange (10.1021/ACS.BIOCHEM.5B00884 )
  • 5BUC: oxidized quinone reductase 2 in complex with ethidium
  • 5LBT: structure of the human quinone reductase 2 (nqo2) in complex with imiquimod
  • 5LBU: structure of the human quinone reductase 2 (nqo2) in complex with to cl097
  • 5LBW: structure of the human quinone reductase 2 (nqo2) in complex with volitinib (10.1126/SCIENCE.AAN4368 )
  • 5LBY: structure of the human quinone reductase 2 (nqo2) in complex with crenolanib (10.1126/SCIENCE.AAN4368 )
  • 5LBZ: structure of the human quinone reductase 2 (nqo2) in complex with pacritinib (10.1126/SCIENCE.AAN4368 )